Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Mather

Showing results (71-80 of 91) with videos related to

Pageof 10
Sort By:
Clinical Pharmacokinetics|October 7, 1997
Pharmacokinetic interactions with felbamate. In vitro-in vivo correlationP Glue, C R Banfield, J L Perhach, et al.
Neurology|December 15, 2004
Visual perception in Parkinson disease dementia and dementia with Lewy bodiesU P Mosimann, G Mather, K A Wesnes, et al.
Chirality|February 26, 2000
Nefopam enantiomers: preclinical pharmacology/toxicology and pharmacokinetic characteristics in healthy subjects after intravenous administrationG G Mather, R Labroo, M E Le Guern, et al.
Emerging Infectious Diseases|September 25, 2024
Age- and Sex-Specific Differences in Lyme Disease Health-Related Behaviors, Ontario, Canada, 2015-2022Janica A Adams, Victoria Osasah, Katherine Paphitis, et al.
Journal of Clinical Pharmacology|March 20, 1998
Lack of effect of azelastine and ketoconazole coadministration on electrocardiographic parameters in healthy volunteersJ Morganroth, W H Lyness, J L Perhach, et al.
International Journal of Cancer|February 26, 2011
Differential interactions between statins and P-glycoprotein: implications for exploiting statins as anticancer agentsCarolyn A Goard, Richard G Mather, Balpreet Vinepal, et al.
Molecular Metabolism|January 13, 2024
RIPK3 promotes islet amyloid-induced β-cell loss and glucose intolerance in a humanized mouse model of type 2 diabetesNoyonika Mukherjee, Christopher J Contreras, Li Lin, et al.
British Medical Journal|April 17, 1976
Myocardial infarction: a comparison between home and hospital care for patientsH G Mather, D C Morgan, N G Pearson, et al.
Molecular Cancer Therapeutics|December 17, 2010
Phase I clinical trial of MPC-6827 (Azixa), a microtubule destabilizing agent, in patients with advanced cancerApostolia-Maria Tsimberidou, Wallace Akerley, Matthias C Schabel, et al.
British Medical Journal (Clinical Research Ed.)|November 8, 1986
Trial of early nifedipine in acute myocardial infarction: the Trent studyR G Wilcox, J R Hampton, D C Banks, et al.
Pageof 10

Showing results (71-80 of 91) with videos related to

Sort By:
Pageof 10
Clinical Pharmacokinetics|October 7, 1997
Pharmacokinetic interactions with felbamate. In vitro-in vivo correlationP Glue, C R Banfield, J L Perhach, et al.
Neurology|December 15, 2004
Visual perception in Parkinson disease dementia and dementia with Lewy bodiesU P Mosimann, G Mather, K A Wesnes, et al.
Chirality|February 26, 2000
Nefopam enantiomers: preclinical pharmacology/toxicology and pharmacokinetic characteristics in healthy subjects after intravenous administrationG G Mather, R Labroo, M E Le Guern, et al.
Emerging Infectious Diseases|September 25, 2024
Age- and Sex-Specific Differences in Lyme Disease Health-Related Behaviors, Ontario, Canada, 2015-2022Janica A Adams, Victoria Osasah, Katherine Paphitis, et al.
Journal of Clinical Pharmacology|March 20, 1998
Lack of effect of azelastine and ketoconazole coadministration on electrocardiographic parameters in healthy volunteersJ Morganroth, W H Lyness, J L Perhach, et al.
International Journal of Cancer|February 26, 2011
Differential interactions between statins and P-glycoprotein: implications for exploiting statins as anticancer agentsCarolyn A Goard, Richard G Mather, Balpreet Vinepal, et al.
Molecular Metabolism|January 13, 2024
RIPK3 promotes islet amyloid-induced β-cell loss and glucose intolerance in a humanized mouse model of type 2 diabetesNoyonika Mukherjee, Christopher J Contreras, Li Lin, et al.
British Medical Journal|April 17, 1976
Myocardial infarction: a comparison between home and hospital care for patientsH G Mather, D C Morgan, N G Pearson, et al.
Molecular Cancer Therapeutics|December 17, 2010
Phase I clinical trial of MPC-6827 (Azixa), a microtubule destabilizing agent, in patients with advanced cancerApostolia-Maria Tsimberidou, Wallace Akerley, Matthias C Schabel, et al.
British Medical Journal (Clinical Research Ed.)|November 8, 1986
Trial of early nifedipine in acute myocardial infarction: the Trent studyR G Wilcox, J R Hampton, D C Banks, et al.
Pageof 10